7XY Stock Chart & Stats
€2.22
-€0.17(-4.25%)
At close: 4:00 PM EST
€2.22
-€0.17(-4.25%)
Day’s Range― - ―
52-Week Range€1.64 - €3.57
Previous CloseN/A
Volume0.00
Average Volume (3M)100.00
Market Cap
€275.82M
Enterprise Value€5.10B
Total Cash (Recent Filing)€91.20M
Total Debt (Recent Filing)€1.69B
Price to Earnings (P/E)35.2
Beta1.04
Next Earnings
Feb 11, 2027EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.54
Shares Outstanding159,840,960
10 Day Avg. Volume300
30 Day Avg. Volume100
Financial Highlights & Ratios
PEG Ratio-2.52
Price to Book (P/B)0.92
Price to Sales (P/S)2.27
P/FCF Ratio22.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.73Price Target Upside22.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.08
Revenue Forecast (FY)€255.14M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe strong TTM revenue increase, together with multi-year expansion, indicates continued market demand for Swedencare’s products. Sustained top-line growth can broaden distribution, increase brand reach, and provide a larger base from which operating efficiency and future earnings can develop.
Manageable LeverageModerate leverage and a sizeable equity base provide financial resilience and preserve flexibility for ongoing operations, product investment, and expansion. The improvement from 2025 also reduces balance-sheet pressure, making the company better positioned to absorb operating volatility.
Diversified Branded Product ModelSelling branded, consumable pet-health products through veterinary, retail, and online channels diversifies customer access and reduces reliance on one route to market. Repeat purchases tied to ongoing pet care can support recurring demand, while international distribution broadens growth opportunities.
Bears Say
Margin CompressionThe substantial decline in gross margin and low net margin show that revenue growth is not translating efficiently into bottom-line earnings. If the pressure persists, weaker profitability could constrain reinvestment, reduce earnings resilience, and make future growth more dependent on continued sales expansion.
Weakening Cash ConversionPositive cash generation remains a support, but declining free cash flow and operating cash flow below net income indicate weakening earnings conversion. Persistent deterioration could reduce internally funded investment capacity and leave less cash available for expansion, debt management, or shareholder returns.
Low Return On EquityA very low return on equity suggests Swedencare is currently generating limited profit from the capital invested in the business. Unless returns improve, the sizeable equity base may not translate into attractive earnings power, potentially limiting the efficiency and durability of future growth.
Swedencare AB News
7XY FAQ
What was Swedencare AB’s price range in the past 12 months?
Swedencare AB lowest stock price was €1.64 and its highest was €3.56 in the past 12 months.
What is Swedencare AB’s market cap?
Swedencare AB’s market cap is €275.82M.
When is Swedencare AB’s upcoming earnings report date?
Swedencare AB’s upcoming earnings report date is Feb 11, 2027 which is in 102 days.
How were Swedencare AB’s earnings last quarter?
Swedencare AB released its earnings results on Oct 21, 2026. The company reported €0.017 earnings per share for the quarter, missing the consensus estimate of €0.03 by -€0.013.
Is Swedencare AB overvalued?
According to Wall Street analysts Swedencare AB’s price is currently Undervalued.
Does Swedencare AB pay dividends?
Swedencare AB does not currently pay dividends.
What is Swedencare AB’s EPS estimate?
Swedencare AB’s EPS estimate is 0.03.
How many shares outstanding does Swedencare AB have?
Swedencare AB has 159,840,960 shares outstanding.
What happened to Swedencare AB’s price movement after its last earnings report?
Swedencare AB reported an EPS of €0.017 in its last earnings report, missing expectations of €0.03. Following the earnings report the stock price went down -0.246%.
Which hedge fund is a major shareholder of Swedencare AB?
Currently, no hedge funds are holding shares in DE:7XY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Swedencare AB
Swedencare AB (publ), an enterprise established in 1993 and headquartered in Malmö, Sweden, operates with its subsidiaries to develop, produce, market, and sell a wide array of healthcare products, predominantly for animals. The company's flagship offering is the ProDen PlaqueOff line, focused on dental hygiene for dogs and cats. This popular range includes a food supplement powder designed to reduce plaque and tartar buildup, along with various chewable formats such as dental bites, bones (including mini versions for smaller dogs), and soft chews suitable for both felines and canines. Beyond dental care, Swedencare provides an extensive selection of nutritional supplements under the NutriScience brand for cats, dogs, and horses. These products address diverse health requirements: Glucosamine and Stomax aid in the rejuvenation of joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid supports joint function and mobility; KalmAid offers a calming effect for anxious dogs; while OmegaAid and RevitalAid are formulated to promote healthy skin and coats. Furthermore, the company manufactures specialized supplements for horses, including Gastrocare to alleviate gastric pain and enhance appetite; Equine Gold for overall vitality; a horse-specific ArthriAid to assist with cartilage formation; and AnxiKalm, aimed at soothing excitable horses. Interestingly, Swedencare also caters to human health with ProDen PlaqueOff Teeth and Gums, a natural dietary supplement designed to boost oral hygiene and prevent tartar accumulation. The company's products are distributed through a broad network that includes pharmacies, veterinary clinics, pet stores, animal hospitals, and online channels.
7XY Stock 12 Month Forecast
Average Price Target
€2.73
▲(22.88% Upside)